Dr. Giulio SUPERTI-FURGA Professor, Institute of Pharmacology, Medical University of Vienna; Scientific Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna
CV
| 1987-1991 | Ph.D., Molecular Biology, University of Zurich |
| 1991-1993 | Postdoctoral fellow, EMBO and EU Postdoc EMBL - European Molecular Biology Laboratory, Heidelberg |
| 1993-2004 | Staff Scientist, Team Leader; EMBL - European Molecular Biology Laboratory, Heidelberg |
| 1997-2000 | Guest Professor, Molecular Biology, University of Bologna |
| 2000-2005 | Founder and Scientific Director, Cellzome AG and Inc., Heidelberg and Cambridge |
| 2005-2014 | Guest Professor, Molecular Pharmacology, Medical University of Vienna |
| since 2005 | Director, CeMM - Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna |
| since 2015 | Professor, Medical Systems Biology, Center for Physiology and Pharmacology, Medical University of Vienna |
| since 2017 | Member, Scientific Council of the European Research Council, Brussels |
Mitgliedschaften
| Member of the Austrian Academy of Sciences | |
| Member of the German Academy of Sciences Leopoldina | |
| Member of the European Molecular Biology Organization (EMBO) | |
| Chair of EMBL Alumni Association |
Publikationen
| Vladimer GI, Snijder B, et al.: Global survey of the immunomodulatory potential of common drugs. Nat Chem Biol., 2017 | |
| Köberlin MS, et al.: A conserved circular network of coregulated lipids modulates innate immune responses. Cell., 2015 | |
| Rebsamen M, et al.: SLC38A9 is a component of the lysosomal amino-acid-sensing machinery that controls mTORC1., 2015 | |
| Pichlmair A, et al.: Viral immune modulators perturb the human molecular network by common and unique strategies., 2012 |
Auszeichnungen
| Prize of the City of Vienna for Natural Sciences, 2011 | |
| Austria's Scientist of the year, 2011 | |
| 4 ERC Grants | |
| Commander of the Order of Merit, Republic of Italy, Knight Officer, 2009 |
